Human immunodeficiency virus type 1 (HIV-1) is the etiological agent of AIDS (5, 18, 32) . Following acute infection by HIV-1, the progression of the disease includes an asymptomatic period which varies in length from a few months to many years. To some extent this clinical latency correlates with microbiological latency, in which viral replication proceeds very slowly, if at all (14, 47) . This period of latency may provide a biologic advantage to the virus and allow evasion of the host immune system. Although the mechanism which induces latency in viral replication is poorly understood, it is believed that multiple steps in the viral life cycle may participate in this event. These processes include reverse transcription, integration and methylation of viral cDNA, and transcription and nuclear export of viral mRNA (for a review, see reference 6).
After integration of HIV-1 DNA into the host genome, the collaborative action of viral and cellular factors on the long terminal repeat (LTR) determines the extent of HIV-1 gene transcription and the level of viral replication in the infected cells. In this respect, the status of several parameters, including the rate of cell proliferation, degree of differentiation, extent of activation, and phase in the mitotic cycle, becomes important, as these parameters influence the repertoire of regulatory proteins which can impact upon viral gene transcription. In support of this concept, earlier studies have indicated that resting peripheral blood lymphocytes sustain very low levels of viral expression, if any at all, but that high levels of viral replication can be induced through antigenic or mitogenic stimulation of these cells (16, 37) . Also, differentiation of peripheral blood monocytes and promonocytic cell lines enhances productive HIV-1 infection in vitro (27, 45) . Furthermore, HIV-1 replication in monocytes involves a proliferation-dependent step which occurs following stimulation by interleukin 4 (45). Progression through the cell cycle is a feature of activation and differentiation in lymphoid and monocytic cells and correlates with the level of HIV-1 replication. Commitment of a cell to enter the cell cycle involves modification of preexisting proteins and de novo expression of genes. It seems reasonable to speculate that cellular factors involved in cell proliferation simultaneously affect HIV-1 expression at the level of transcription.
Basal levels of viral transcription are mediated by a core promoter consisting of the TATAA element and the GC-rich motif, which constitutes three Sp1-binding sites (19, 24) . Located immediately upstream of the core promoter is the HIV-1 enhancer region, which contains two binding sites for the transcription factor nuclear factor kappa B (NF-B) (26, 39) . This enhancer functions as the final common target for a wide variety of stimuli, including cytokines such as tumor necrosis factor alpha and mitogens which simultaneously activate T lymphocytes and up-regulate HIV-1 transcription (40, 46). The HIV-1 LTR also contains binding sites for numerous other cellular factors, including YY1, TCF-1, HIP, LBP, HIV-TF1, USF, NFAT, c-myb, and AP-1 (for a review, see reference 20). In general, the role of these transcription factors in HIV-1 expression in vivo is not well established. In addition to the influence of cellular factors, viral transcription is largely influenced by Tat (3). This viral regulatory protein is believed to enhance the efficiency of elongation of transcripts initiated by RNA polymerase II (36).
E2F 1 is among the numerous proteins involved in regulating the progression of mammalian cells through the cell proliferation cycle. The promoters of several genes which are activated in mid to late G 1 contain putative E2F-binding sites. These genes include those for dihydrofolate reductase, thymidine kinase, and DNA polymerase alpha; c-myb, c-myc, and cdc2; and the gene for E2F 1 itself (for a review, see references 15 and 41). Presumably, E2F 1 influences the cell cycle, at least in part, by affecting the level of transcription of the above-mentioned genes, which are important for the G 1 -to-S phase transition. The activity, as well as the function, of E2F is determined by the level of free E2F and by the formation of complexes with a variety of cofactors, including RB, p107, p130, cyclin A, cyclin E, and cdk2 at various points in the cell cycle (4, 8, 9, 11, 30) . Although the functional differences between the various forms of E2F have not yet been determined, the multifunctional potential of E2F and its complexes is suggested by observations that the E2F-binding sites in the c-myc and B-myb promoters are involved in both the repression of these genes during G 0 and activation of these genes during G 1 and S phases (22, 29) .
The data presented in this study suggest that E2F 1 can also function as a repressor of transcription from a promoter which does not contain consensus E2F 1 -binding sites. We report that overexpression of E2F 1 results in suppression of basal transcriptional activity and Tat-mediated transactivation of the HIV-1 LTR and decreases the efficiency of viral replication in transfected cells.
MATERIALS AND METHODS
Cells and tissue culture conditions. The following were obtained from the American Type Culture Collection: U-87MG cells, derived from a human glioblastoma; HeLa cells, derived from a human cervical epithelioid carcinoma; SW40 cells, derived from a human adenocarcinoma of the colon; RD cells, derived from a human rhabdomyosarcoma; and U-937 cells, derived from a human histiocytic lymphoma. The SupT 1 cell line was derived from a human pediatric T-cell lymphoma (kindly provided by D. Kozbor, Thomas Jefferson University). U-87MG, HeLa, SW40, and RD cells were maintained as monolayer cultures in Dulbecco's modified Eagle's medium (DMEM), while U-937 and SupT 1 cells were grown in suspension in RPMI 1640 medium at 37ЊC in 5% CO 2 . DMEM and RPMI 1640 medium were supplemented with 10% (vol/vol) heatinactivated fetal bovine serum and 1% penicillin-streptomycin.
Plasmid constructions. The proviral DNA construct pZ6Neo was originated from cells infected with HIV Zr6 (48). Plasmid pCD15-CAT contains the entire U3 region and 75 nucleotides of the R region of the HIV-1 LTR inserted 5Ј to the chloramphenicol acetyltransferase (CAT) gene in a pBR322-derived vector (3). The construction of deletion plasmids p(Ϫ381/ϩ71), p(Ϫ321/ϩ71), p(Ϫ273/ ϩ71), p(Ϫ219/ϩ71), p(Ϫ117/ϩ80), p(Ϫ117/ϩ3), and p(Ϫ80/ϩ3) has been reported previously (13, 50) . The p650 AvaI construct contains 263 bp upstream and approximately 300 bp downstream of the murine c-myc promoter P2 initiation site (ϩ1) and includes the E2F 1 -binding site (43).
The expression plasmids ptat and pact-tat contain the tat coding region of HIV-1 under the control of the HIV-1 LTR (28) and ␤-actin promoters, respectively. To generate plasmids pE2F 1 sense (pE2F 1S ) and pE2F 1 antisense (pE2F 1AS ), an 804-bp HindIII-BamHI DNA fragment of the cytomegalovirus immediate-early (CMVIE) promoter from pSSH (gift from Jay Nelson), containing DNA sequence from nucleotide position Ϫ750 to ϩ54 relative to the transcription start site (ϩ1), was placed upstream of the Moloney murine sarcoma virus poly(A) site in a pBR322 background and named pCSMA 1 . The HindIII-BamHI fragment of pCMV-␤-globin E2F 1 (22a) containing 200 bp of the 5Ј untranslated region of the ␤-globin gene fused to the full-length E2F 1 cDNA (23) was then cloned into the SmaI site of pCSMA 1 in the sense and antisense orientations, yielding pE2F 1S and pE2F 1AS , respectively. The integrity of these clones was examined by direct DNA sequencing.
Transfections. U-87MG, HeLa, SW40, and RD cells were transfected by the calcium phosphate coprecipitation method (21), whereas SupT 1 and U-937 cells were transfected by the DEAE-dextran method (12). For CAT assays, 0.5 ϫ 10 6 cells were plated in 60-mm-diameter dishes 24 h prior to transfection by the calcium phosphate method. Each plate of cells was transfected with 10 to 15 g of DNA, depending on the experiment. A total of 10 7 cells were transfected with 20 g of DNA by the DEAE-dextran method. For reverse transcriptase (RT) analysis, 10 6 cells were plated in 100-mm-diameter dishes and transfected with 30 g of DNA. The amount of plasmid DNA containing the promoter sequence which drives the E2F 1 cDNA was kept constant by the addition of pCSMA 1 . The
